Modern Retina Latest

Introducing: Modern Retina
Introducing: Modern RetinaOphthalmology Times is pleased to introduce a new clinical and educational platform for retina specialists called Modern Retina.
Treat-and-extend may lead to better AMD resultsTreating neovascular age-related macular degeneration (nAMD) patients with anti-vascular endothelial growth factor (anti-VEGF) ranibizumab (Lucentis, Genentech) on a monthly regimen has produced “great results” in clinical trials, said Prof. Mark C. Gillies, MBBS, PhD. “But what happens after that and what happens in real world practice?”
‘Ideal’ disease control leads to better nAMD outcomesNeovascular age-related macular degeneration (nAMD) is well-known as a heterogeneous disease with variable natural history and variable treatment response, said Carl D. Regillo, MD, FACS. Many patients do well without monthly treatment as noted in HARBOR PRN arms.
Paradigm shifting for ILM peeling, prone position after vitrectomyPeeling of the internal limiting membrane has increasingly become a dogma of surgical retina, while maintenance of the face-down positioning may become anachronistic in many cases.
How to manage retinal disease in pregnant patients
How to manage retinal disease in pregnant patientsPregnant patients require special care and surveillance when retinal diseases are present.